Nanexa AB - Home

VISION & MISSION

Nanexa will be a world leading drug development company for Long Acting Injectables, developing a new generation of innovative drug products enabled by our unique PharmaShell® technology”

In its state-of-the-art pilot plant and labs in Uppsala, Nanexa runs the development of own product projects and collaborative projects with other pharmaceutical companies, based on the PharmaShell® system.

PRESSRELEASES

6 December, 2022

Nanexa has started the Phase 1 study of NEX-20 according to plan

Nanexa AB (publ) today announced that the first dose of NEX-20 has been administrated in the Phase 1 study NEX-20-01.

16 November, 2022

Nanexa AB and VitriVax, Inc. have resolved the patent infringement lawsuit

Nanexa AB and VitriVax, Inc. jointly announce that they have resolved the patent infringement lawsuit filed by Nanexa AB against VitriVax, Inc. in the United States District Court for the District of Delaware.